RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors
01.11.2023 - SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) - RayzeBio, Inc. (Nasdaq: RYZB), a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced the appointment of Tim Van Hauwermeiren to ... Seite 1